<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	xmlns:media="http://search.yahoo.com/mrss/"
	>

<channel>
	<title>Multiple Myeloma Charitable Foundation</title>
	<atom:link href="http://mmcf.wordpress.com/feed/" rel="self" type="application/rss+xml" />
	<link>http://mmcf.wordpress.com</link>
	<description></description>
	<lastBuildDate>Wed, 26 Aug 2009 05:20:08 +0000</lastBuildDate>
	<generator>http://wordpress.com/</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<cloud domain='mmcf.wordpress.com' port='80' path='/?rsscloud=notify' registerProcedure='' protocol='http-post' />
<image>
		<url>http://www.gravatar.com/blavatar/9773b9203b6dc46490ad45008d6fe448?s=96&#038;d=http://s.wordpress.com/i/buttonw-com.png</url>
		<title>Multiple Myeloma Charitable Foundation</title>
		<link>http://mmcf.wordpress.com</link>
	</image>
			<item>
		<title>Hello to all&#8230;</title>
		<link>http://mmcf.wordpress.com/2009/08/05/hello-to-all/</link>
		<comments>http://mmcf.wordpress.com/2009/08/05/hello-to-all/#comments</comments>
		<pubDate>Thu, 06 Aug 2009 01:34:33 +0000</pubDate>
		<dc:creator>Eve</dc:creator>
				<category><![CDATA[Eve's Story Continues...]]></category>

		<guid isPermaLink="false">http://mmcf.wordpress.com/?p=279</guid>
		<description><![CDATA[I was reminded very recently that there are people that look at this blog to see how I am doing with my personal cancer journey.  It made me think that I&#8217;d better get something written.
There have been lots of ups and downs over the past year.  Up until about three months ago, the &#8220;beast within&#8221; [...]<img alt="" border="0" src="http://stats.wordpress.com/b.gif?host=mmcf.wordpress.com&blog=2658973&post=279&subd=mmcf&ref=&feed=1" />]]></description>
		<wfw:commentRss>http://mmcf.wordpress.com/2009/08/05/hello-to-all/feed/</wfw:commentRss>
		<slash:comments>2</slash:comments>
	
		<media:content url="http://1.gravatar.com/avatar/7a05b18f2310e0a1af97b749e05a1af9?s=96&#38;d=identicon&#38;r=G" medium="image">
			<media:title type="html">Eve</media:title>
		</media:content>
	</item>
		<item>
		<title>Updates 12/4/08</title>
		<link>http://mmcf.wordpress.com/2009/01/03/updates-12408/</link>
		<comments>http://mmcf.wordpress.com/2009/01/03/updates-12408/#comments</comments>
		<pubDate>Sun, 04 Jan 2009 01:28:32 +0000</pubDate>
		<dc:creator>Eve</dc:creator>
				<category><![CDATA[MM Updates]]></category>

		<guid isPermaLink="false">http://mmcf.wordpress.com/?p=236</guid>
		<description><![CDATA[Multiple Myeloma and farming. A systematic review of 30 years of research. Where next?:  http://7thspace.com/headlines/297830/multiple_myeloma_and_farming_a_systematic_review_of_30_years_of_research_where_next.html
Collaboration with Luc Montagnier and Howard Urnovitz: http://www.businesswire.com/portal/site/home/permalink/?ndmViewId=news_view&#38;newsId=20081118005583&#38;newsLang=en
New study backs solvent, leukemia link:  http://www.reuters.com/article/healthNews/idUSTRE4AH85R20081118
New Data Will Be Presented at ASH on VELCADE(R) (Bortezomib) for Injection-Based Therapies in Multiple Myeloma and Non-Hodgkin&#8217;s Lymphoma:  http://www.marketwatch.com/news/story/New-Data-Will-Be-Presented/story.aspx?guid=%7BE97D11F5-5E5D-44A9-9DE8-107A45ED8C6F%7D
Balloon kyphoplasty may be effective in [...]<img alt="" border="0" src="http://stats.wordpress.com/b.gif?host=mmcf.wordpress.com&blog=2658973&post=236&subd=mmcf&ref=&feed=1" />]]></description>
		<wfw:commentRss>http://mmcf.wordpress.com/2009/01/03/updates-12408/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
	
		<media:content url="http://1.gravatar.com/avatar/7a05b18f2310e0a1af97b749e05a1af9?s=96&#38;d=identicon&#38;r=G" medium="image">
			<media:title type="html">Eve</media:title>
		</media:content>
	</item>
		<item>
		<title>Updates 10/29/08</title>
		<link>http://mmcf.wordpress.com/2009/01/03/updates-102908/</link>
		<comments>http://mmcf.wordpress.com/2009/01/03/updates-102908/#comments</comments>
		<pubDate>Sun, 04 Jan 2009 01:21:53 +0000</pubDate>
		<dc:creator>Eve</dc:creator>
				<category><![CDATA[MM Updates]]></category>

		<guid isPermaLink="false">http://mmcf.wordpress.com/?p=234</guid>
		<description><![CDATA[Outpatient Stem Cell Transplant Feasible for Multiple Myeloma:  http://www.cancerpage.com/news/article.asp?id=12756
Nifuroxazide inhibits survival of multiple myeloma cells by directly inhibiting STAT:  http://bloodjournal.hematologylibrary.org/cgi/content/abstract/blood-2007-12-129718v1
Celgene Corporation and Acceleron Pharma Initiate Phase 2 Study of ACE-011 in Patients with Multiple Myeloma:  http://www.marketwatch.com/news/story/celgene-corporation-acceleron-pharma-initiate/story.aspx?guid=%7b277E3FD5-229F-42F6-AF14-FADC075CAD3F%7d&#38;dist=hppr
RocketBoom Founder Fighting For Father’s Life; Meanwhile, Drug Company Is Committing PR Suicide: http://www.techcrunch.com/2008/10/14/rocketboom-founder-fighting-for-fathers-life-meanwhile-drug-company-committing-pr-suicide/
Biogen, Tysabri &#38; A [...]<img alt="" border="0" src="http://stats.wordpress.com/b.gif?host=mmcf.wordpress.com&blog=2658973&post=234&subd=mmcf&ref=&feed=1" />]]></description>
		<wfw:commentRss>http://mmcf.wordpress.com/2009/01/03/updates-102908/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
	
		<media:content url="http://1.gravatar.com/avatar/7a05b18f2310e0a1af97b749e05a1af9?s=96&#38;d=identicon&#38;r=G" medium="image">
			<media:title type="html">Eve</media:title>
		</media:content>
	</item>
		<item>
		<title>Attacking Cancer Stem Cells</title>
		<link>http://mmcf.wordpress.com/2009/01/03/attacking-cancer-stem-cells/</link>
		<comments>http://mmcf.wordpress.com/2009/01/03/attacking-cancer-stem-cells/#comments</comments>
		<pubDate>Sun, 04 Jan 2009 01:13:55 +0000</pubDate>
		<dc:creator>Eve</dc:creator>
				<category><![CDATA[MM Updates]]></category>

		<guid isPermaLink="false">http://mmcf.wordpress.com/?p=232</guid>
		<description><![CDATA[Wednesday, October 08, 2008
Attacking Cancer Stem Cells
A screening approach identifies drugs that halt cells that feed tumors.
By Courtney Humphries
All cancer cells were once thought to be equal, but recent research suggests otherwise. A growing body of evidence indicates that only certain cancer cells are capable of generating and maintaining a tumor. Dubbed cancer stem cells, [...]<img alt="" border="0" src="http://stats.wordpress.com/b.gif?host=mmcf.wordpress.com&blog=2658973&post=232&subd=mmcf&ref=&feed=1" />]]></description>
		<wfw:commentRss>http://mmcf.wordpress.com/2009/01/03/attacking-cancer-stem-cells/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
	
		<media:content url="http://1.gravatar.com/avatar/7a05b18f2310e0a1af97b749e05a1af9?s=96&#38;d=identicon&#38;r=G" medium="image">
			<media:title type="html">Eve</media:title>
		</media:content>
	</item>
		<item>
		<title>Treatment of Myeloma: Cure vs Control</title>
		<link>http://mmcf.wordpress.com/2009/01/03/treatment-of-myeloma-cure-vs-control/</link>
		<comments>http://mmcf.wordpress.com/2009/01/03/treatment-of-myeloma-cure-vs-control/#comments</comments>
		<pubDate>Sun, 04 Jan 2009 01:11:40 +0000</pubDate>
		<dc:creator>Eve</dc:creator>
				<category><![CDATA[MM Updates]]></category>

		<guid isPermaLink="false">http://mmcf.wordpress.com/?p=230</guid>
		<description><![CDATA[Treatment of Myeloma: Cure vs Control
S. VINCENT RAJKUMAR, MD
From the Division of Hematology, Mayo Clinic, Rochester, MN.
Supported in part by grants CA62242, CA85818, CA93842, and CA100080 from the National Cancer Institute, Bethesda, MD.
Individual reprints of this article are not available. Address correspondence to S. Vincent Rajkumar, MD, Division of Hematology, Mayo Clinic, 200 First St [...]<img alt="" border="0" src="http://stats.wordpress.com/b.gif?host=mmcf.wordpress.com&blog=2658973&post=230&subd=mmcf&ref=&feed=1" />]]></description>
		<wfw:commentRss>http://mmcf.wordpress.com/2009/01/03/treatment-of-myeloma-cure-vs-control/feed/</wfw:commentRss>
		<slash:comments>2</slash:comments>
	
		<media:content url="http://1.gravatar.com/avatar/7a05b18f2310e0a1af97b749e05a1af9?s=96&#38;d=identicon&#38;r=G" medium="image">
			<media:title type="html">Eve</media:title>
		</media:content>
	</item>
		<item>
		<title>Updates from Inside Blood 9/28/08</title>
		<link>http://mmcf.wordpress.com/2009/01/03/updates-from-inside-blood-92808/</link>
		<comments>http://mmcf.wordpress.com/2009/01/03/updates-from-inside-blood-92808/#comments</comments>
		<pubDate>Sun, 04 Jan 2009 01:02:46 +0000</pubDate>
		<dc:creator>Eve</dc:creator>
				<category><![CDATA[MM Updates]]></category>

		<guid isPermaLink="false">http://mmcf.wordpress.com/?p=228</guid>
		<description><![CDATA[Blood, 15 September 2008, Vol. 112, No. 6, pp. 2177-2178.
NEOPLASIA 
Comment on Oerlemans, page 2489
Many facets of bortezomib resistance/susceptibility
Shaji Kumar, and S. Vincent Rajkumar
MAYO CLINIC
In this issue of Blood, Oerlemans and colleagues present a fascinating report, detailing a mechanism by which cells acquire resistance to therapy with the proteasome inhibitor, bortezomib.
Proteasome inhibition represents one of [...]<img alt="" border="0" src="http://stats.wordpress.com/b.gif?host=mmcf.wordpress.com&blog=2658973&post=228&subd=mmcf&ref=&feed=1" />]]></description>
		<wfw:commentRss>http://mmcf.wordpress.com/2009/01/03/updates-from-inside-blood-92808/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
	
		<media:content url="http://1.gravatar.com/avatar/7a05b18f2310e0a1af97b749e05a1af9?s=96&#38;d=identicon&#38;r=G" medium="image">
			<media:title type="html">Eve</media:title>
		</media:content>
	</item>
		<item>
		<title>Combination Therapy Helps to Combat Myeloma 9/28/08</title>
		<link>http://mmcf.wordpress.com/2009/01/03/combination-therapy-helps-to-combat-myeloma-92808/</link>
		<comments>http://mmcf.wordpress.com/2009/01/03/combination-therapy-helps-to-combat-myeloma-92808/#comments</comments>
		<pubDate>Sat, 03 Jan 2009 20:08:06 +0000</pubDate>
		<dc:creator>Eve</dc:creator>
				<category><![CDATA[MM Updates]]></category>

		<guid isPermaLink="false">http://mmcf.wordpress.com/?p=226</guid>
		<description><![CDATA[By Steven Reinberg
HealthDay Reporter
WEDNESDAY, Aug. 27 (HealthDay News) &#8212; Patients with multiple myeloma who could not tolerate high dose chemotherapy lived longer and better by adding the drug Velcade to standard treatment, a new study found.
The finding could make multiple myeloma, a cancer of the blood&#8217;s plasma cells, a chronic rather than a lethal disease. [...]<img alt="" border="0" src="http://stats.wordpress.com/b.gif?host=mmcf.wordpress.com&blog=2658973&post=226&subd=mmcf&ref=&feed=1" />]]></description>
		<wfw:commentRss>http://mmcf.wordpress.com/2009/01/03/combination-therapy-helps-to-combat-myeloma-92808/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
	
		<media:content url="http://1.gravatar.com/avatar/7a05b18f2310e0a1af97b749e05a1af9?s=96&#38;d=identicon&#38;r=G" medium="image">
			<media:title type="html">Eve</media:title>
		</media:content>
	</item>
		<item>
		<title>EU approves VELCADE for all stages of multiple myeloma 9/9/08</title>
		<link>http://mmcf.wordpress.com/2009/01/03/eu-approves-velcade-for-all-stages-of-multiple-myeloma-9908/</link>
		<comments>http://mmcf.wordpress.com/2009/01/03/eu-approves-velcade-for-all-stages-of-multiple-myeloma-9908/#comments</comments>
		<pubDate>Sat, 03 Jan 2009 20:04:53 +0000</pubDate>
		<dc:creator>Eve</dc:creator>
				<category><![CDATA[MM Updates]]></category>

		<guid isPermaLink="false">http://mmcf.wordpress.com/?p=224</guid>
		<description><![CDATA[EU approves VELCADE for all stages of multiple myeloma
Source: (cancerfacts.com)
Tuesday, September 09, 2008 
HIGH WYCOMBE, England – Sept. 9, 2008 – The European Commission has approved VELCADE® in combination with melphalan and prednisone for the first-line treatment of patients with multiple myeloma who are not eligible for high-dose chemotherapy with bone marrow transplant. The approval [...]<img alt="" border="0" src="http://stats.wordpress.com/b.gif?host=mmcf.wordpress.com&blog=2658973&post=224&subd=mmcf&ref=&feed=1" />]]></description>
		<wfw:commentRss>http://mmcf.wordpress.com/2009/01/03/eu-approves-velcade-for-all-stages-of-multiple-myeloma-9908/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
	
		<media:content url="http://1.gravatar.com/avatar/7a05b18f2310e0a1af97b749e05a1af9?s=96&#38;d=identicon&#38;r=G" medium="image">
			<media:title type="html">Eve</media:title>
		</media:content>
	</item>
		<item>
		<title>VELCADE For Multiple Myeloma Receives Front-line Approval In Canada</title>
		<link>http://mmcf.wordpress.com/2009/01/03/velcade-for-multiple-myeloma-receives-front-line-approval-in-canada/</link>
		<comments>http://mmcf.wordpress.com/2009/01/03/velcade-for-multiple-myeloma-receives-front-line-approval-in-canada/#comments</comments>
		<pubDate>Sat, 03 Jan 2009 20:03:19 +0000</pubDate>
		<dc:creator>Eve</dc:creator>
				<category><![CDATA[MM Updates]]></category>

		<guid isPermaLink="false">http://mmcf.wordpress.com/?p=222</guid>
		<description><![CDATA[VELCADE (bortezomib) for Injection has received Health Canada approval for front-line (first) treatment of multiple myeloma, a fatal blood cancer. As part of combination therapy, VELCADE is indicated for the treatment of patients with previously untreated multiple myeloma who are unsuitable for stem cell transplantation. With this new approval, patients with multiple myeloma can now [...]<img alt="" border="0" src="http://stats.wordpress.com/b.gif?host=mmcf.wordpress.com&blog=2658973&post=222&subd=mmcf&ref=&feed=1" />]]></description>
		<wfw:commentRss>http://mmcf.wordpress.com/2009/01/03/velcade-for-multiple-myeloma-receives-front-line-approval-in-canada/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
	
		<media:content url="http://1.gravatar.com/avatar/7a05b18f2310e0a1af97b749e05a1af9?s=96&#38;d=identicon&#38;r=G" medium="image">
			<media:title type="html">Eve</media:title>
		</media:content>
	</item>
		<item>
		<title>Look Good Feel Better from Cancer.net 9/24/08</title>
		<link>http://mmcf.wordpress.com/2009/01/03/look-good-feel-better-from-cancernet-92408/</link>
		<comments>http://mmcf.wordpress.com/2009/01/03/look-good-feel-better-from-cancernet-92408/#comments</comments>
		<pubDate>Sat, 03 Jan 2009 20:01:06 +0000</pubDate>
		<dc:creator>Eve</dc:creator>
				<category><![CDATA[MM Updates]]></category>

		<guid isPermaLink="false">http://mmcf.wordpress.com/?p=220</guid>
		<description><![CDATA[Look Good Feel Better 
Cancer and cancer treatments, such as chemotherapy, radiation therapy, and surgery, may change your appearance and how you feel about yourself. Common changes include hair loss and skin problems. It is common for people with cancer to feel anxious or distressed when these changes happen. One resource, the Look Good…Feel Better [...]<img alt="" border="0" src="http://stats.wordpress.com/b.gif?host=mmcf.wordpress.com&blog=2658973&post=220&subd=mmcf&ref=&feed=1" />]]></description>
		<wfw:commentRss>http://mmcf.wordpress.com/2009/01/03/look-good-feel-better-from-cancernet-92408/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
	
		<media:content url="http://1.gravatar.com/avatar/7a05b18f2310e0a1af97b749e05a1af9?s=96&#38;d=identicon&#38;r=G" medium="image">
			<media:title type="html">Eve</media:title>
		</media:content>
	</item>
	</channel>
</rss>